Update clinical guideline ในการดูแลผู้รับบริจาคไต จัดทำโดย KDIGO และ The Transplantation society

Download guideline

Download the entire guideline [PDF]

 Quickview to scan the document [LINK]

 KDIGO guidelines - By chapter

Front Matter [PDF]

Disclaimer
Work Group Membership
KDIGO Board Members
Abbreviations and Acronyms
Reference Keys
Abstract
Foreword
Guideline Scope and Intended Users

Section I - Introduction: Immunosuppression [PDF]

Chapter 1: Induction Therapy [PDF]
Chapter 2: Initial Maintenance Immunosuppressive Medications [PDF]
Chapter 3: Long-Term Maintenance Immunosuppressive Medications [PDF]
Chapter 4: Strategies to Reduce Drug Costs [PDF]
Chapter 5: Monitoring Immunosuppressive Medications [PDF]
Chapter 6: Treatment of Acute Rejection [PDF]
Chapter 7: Treatment of Chronic Allograft Injury [PDF]

Section II - Introduction: Graft Monitoring and Infections [PDF]

Chapter 8: Monitoring Kidney Allograft Function [PDF]
Chapter 9: Kidney Allograft Biopsy [PDF]
Chapter 10: Recurrent Kidney Disease [PDF]
Chapter 11: Preventing, Detecting, and Treating Nonadherence [PDF]
Chapter 12: Vaccination [PDF]
Chapter 13: Viral Diseases [PDF]
-13.1: BK Polyoma Virus
-13.2: Cytomegalovirus
-13.3: Epstein-Barr Virus and Post-Transplant Lymphoproliferative Disease
-13.4: Herpes Simplex Virus 1, 2 and Varicella Zoster Virus
-13.5: Hepatitis C Virus
-13.6: Hepatitis B Virus
-13.7: Human Immunodeficiency Virus
Chapter 14: Other Infections [PDF]
-14.1: Urinary Tract Infection
-14.2: Pneumocystis Jirovecii Pneumonia
-14.3: Tuberculosis
-14.4: Candida Prophylaxis

Section III - Introduction: Cardiovascular Disease [PDF]

Chapter 15: Diabetes Mellitus [PDF]
-15.1: Screening for New-Onset Diabetes after Transplantation
-15.2: Managing NODAT or Diabetes Present at Transplantation
Chapter 16: Hypertension, Dyslipidemias, Tobacco Use, and Obesity [PDF]
-16.1: Hypertension
-16.2: Dyslipidemias
-16.3: Tobacco Use
-16.4: Obesity
Chapter 17: Cardiovascular Disease Management [PDF]

Section IV - Introduction: Malignancy [PDF]

Chapter 18: Cancer of the Skin and Lip [PDF]
Chapter 19: Non–Skin Malignancies [PDF]
Chapter 20: Managing Cancer with Reduction of Immunosuppressive Medication [PDF]

Section V - Introduction: Other Complications [PDF]

Chapter 21: Transplant Bone Disease [PDF]
Chapter 22: Hematological Complications [PDF]
Chapter 23: Hyperuricemia and Gout [PDF]
Chapter 24: Growth and Development [PDF]
Chapter 25: Sexual Function and Fertility [PDF]
-25.1: Sexual Function
-25.2: Female Fertility
-25.3: Male Fertility
Chapter 26: Lifestyle [PDF]
Chapter 27: Mental Health [PDF]


Appendix: Methods for Guideline Development [PDF]
Biographic and Disclosure Information [PDF]
Acknowledgments [PDF]
References [PDF]